As protests against police brutality began in late May, Kechia Matthews lay in a hospital bed battling COVID-19: "I really could not breathe at all. Like, I just felt no air, no nothing. It was scary. It was terrifying. It happened fast. I didn't know where it came [from], like, it just hit."
She was treated by a team of doctors at Johns Hopkins University, including Dr. Panagis Galiatsatos, who said, "I couldn't forget how she looked, the fear in her eyes realizing she could die."
Matthews, a Baltimore native, was just about to graduate with a degree in criminal justice and forensic science from Coppin State University. But it wasn't clear if she'd survive. "I've never been as scared in my life," she told correspondent Allison Aubrey of National Public Radio. "I didn't think I was coming home. It was hard."
Young adults are much less likely to die from COVID-19. Dr. Galiatsatos said, "Kechia was telling us her preexisting conditions. As soon as she said diabetes, I mean, my heart sank, right? I wasn't just dealing with now a 27-year-old; I was dealing someone with one of the variables that we know is gonna create a likelihood of worse symptoms."
According to the Centers for Disease Control and Prevention, people with chronic diseases (such as obesity, heart disease and type-2 diabetes) are a staggering 12 times more likely to die from the coronavirus.
And Black Americans have a higher prevalence of these conditions.
Matthews was in the hospital for three weeks, and on a ventilator six days. When she was finally released, she emerged with a new sense of urgency: "Taking my health seriously; I need to," she said. "I don't ever wanna be put in a situation like that again."
But her determination is just one piece of the COVID puzzle. The lifestyle changes needed to tackle chronic disease are often difficult to make in economically-challenged areas.
Dr. Galiatsatos said, "One of the reasons why we see disparities ravage in the minority populations is because those kind of lifestyle requests are really hard to do in neighborhoods that are plagued by homicide, neighborhoods that are plagued by food deserts. And the challenge there is, resources to give them the opportunities to overcome that, were at a pace that, in my opinion, is unethical."
"People are now hungry and they are hurting," said Hassan Amin, who is imam at Masjid Ul-Haqq, a mosque in West Baltimore. "They were hungry and hurting before the virus. Now they're really doing so, because a lot of times the people we serve, these are the ones that are the last hired, first fired."
Dr. Galiatsatos has teamed up with faith leaders, including Imam Amin, to address these obstacles. At a community event at the mosque where fresh produce and grocery gift cards were being handed out, Dr. Galiatsatos answered questions about COVID-19. His goal: to build relationships. "Medicine is a public trust. We can't just know the science, right? We have to know the patient, and we have to know the community."
"So, by bringing him here, you're building bridges?" asked Aubrey.
"Oh, yeah," Imam Amin replied. "It was building bridges, filling in gaps. 'Cause right now, the people don't trust hospitals and doctors."
The hope is that partnerships between between doctors and community leaders (like Imam Amin) can help build trust. The strategy of working with so-called "trusted messengers" is backed by physician Sherita Golden, who is the chief diversity officer at Johns Hopkins Medicine.
"The reasons those trusted messengers are so important is that there are many of these vulnerable communities that are distrustful of the healthcare system, so this is because of prior historical experiences," she said.
From the infamous Tuskeegee syphilis experiment in the 1940s, when treatment was deliberately withheld from Black men, to Dr. James Marion Sims in the 1800s, who performed surgical experiments on enslaved Black women with no anesthesia, the history of racist mistreatment of Black Americans by the medical establishment is well-documented.
And what still persists today is the misperception that Black people are somehow different from other groups of people. Dr Golden said, "There's been sort of this questioning that, 'Are African Americans more genetically or biologically vulnerable to contracting COVID-19?' And there is no evidence of that. There is nothing genetic or biological about working in a service sector where you have to be essential, and you're just gonna get exposed because you happen to be there. So, there is no evidence that genetics is playing into this at all."
But another factor that likely is playing into this: Stress.
"Stress can make people more prone to infection," Dr. Golden said. "So what happens is that, it alters your body's immune response so that you may be less likely to be able to fight infection as well.
"Structural racism, that induces a form of chronic stress, thinking about, 'Where is my next meal going to come from? I've gotta work three shifts tonight. And then, I have to worry about my child getting pulled over by the police.' Like, those chronic stressors, even though you may not feel you are acutely stressed, they are still impacting your hormonal system."
Looking back, COVID-19 survivor Kechia Matthews says she was under tremendous stress when she got the virus: "Working a full-time job. Going to school. Seven classes at one time. Two hours of studying. Three hours of sleep."
And all of that takes its toll. Imam Amin points out Black people in Baltimore and around the country are more likely to have the types of jobs that you cannot do from home: "That means that they are exposed to all kinds of people all day long, coughing and sniffling, whatever, and then they end up maybe catching something, and they end up taking it home to their families."
It's one more reason why Blacks and Latinos are about three times as likely to get COVID-19
But Matthews said she's now full of hope. When she emerged from the hospital to see "Black Lives Matter" painted on streets, and White people joining Black people to protest injustice, she saw it as a symbol of progress.
Her goal is to become an FBI Special Agent: "That's my next career goal. And that also goes along with me and my health goals. You know, you have to be healthy, fit, in shape. So, another thing that's motivating me."
And Dr. Golden said that Matthews deserves a country that rewards that determination: "This is an important time for us as a country to really think about what are the things we value, what do we want to focus on, and how can we use our power of legislation to really address the issues of making our communities healthier, making our communities safer."
Aubrey asked Matthews, "What do you think your role is in pushing for change in your own community?"
"I want my people safe," she replied. "I want them to have someone they can trust. I want to have someone they can look up to."
"You seem hopeful."
"I am hopeful and determined," Matthews replied. "I'm gonna always be hopeful."
For more info:
Story produced by Amol Mhatre. Editor: Ed Givnish.
Read more here:
Building bridges to combat COVID-19 in communities of color - CBS News
- Clemson professor Trudy Mackay elected to the National Academy of Medicine - Clemson News - October 22nd, 2024
- Research sheds new light on the behavior of KRAS gene in pancreatic and colorectal cancer - News-Medical.Net - October 22nd, 2024
- Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon - Nature.com - October 22nd, 2024
- Tailored Genetic Medicine: AAV Gene Therapy and mRNA Vaccines Redefine Healthcare's Future - Intelligent Living - October 22nd, 2024
- The Genetic Link to Parkinson's Disease - Hopkins Medicine - August 27th, 2022
- Epic Bio makes gene therapies by editing the epigenome - Labiotech.eu - August 27th, 2022
- Ovid turns to gene therapy startup to restock drug pipeline - BioPharma Dive - August 27th, 2022
- Whole-exome analysis of 177 pediatric patients with undiagnosed diseases | Scientific Reports - Nature.com - August 27th, 2022
- First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN (valoctocogene roxaparvovec), Approved by European Commission (EC) -... - August 27th, 2022
- Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases - BioSpace - August 27th, 2022
- ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines - Business Wire - August 27th, 2022
- ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene... - August 27th, 2022
- Genetic variants cause different reactions to psychedelic therapy - The Well : The Well - The Well - August 27th, 2022
- Personalized Medicine for Prostate Cancer: What It Is and How It Works - Healthline - August 27th, 2022
- Four radical new fertility treatments just a few years away from clinics - The Guardian - August 27th, 2022
- Why are Rats Used in Medical Research? - MedicalResearch.com - August 27th, 2022
- The Columns Stepping Stones in STEM Washington and Lee University - The Columns - August 27th, 2022
- Study points to new approach to clearing toxic waste from brain Washington University School of Medicine in St. Louis - Washington University School... - August 27th, 2022
- ALS Gene Therapy SynCav1 Found to Extend Survival in Mouse Model |... - ALS News Today - August 27th, 2022
- A New Kind of Chemo | The UCSB Current - The UCSB Current - August 27th, 2022
- Unraveling the mystery of who gets lung cancer and why - Genetic Literacy Project - June 16th, 2022
- How diet and the microbiome affect colorectal cancer - EurekAlert - June 16th, 2022
- Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear... - May 20th, 2022
- Money on the Move: SwanBio, Remix, Locus, Mirvie and More - BioSpace - May 20th, 2022
- DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New Treatments to Patients - PR Newswire - May 20th, 2022
- Brain tumor growth may be halted with breast cancer drug - Medical News Today - May 20th, 2022
- LogicBio Therapeutics to Present at HC Wainwright Global Investment Conference - PR Newswire - May 20th, 2022
- Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene... - May 20th, 2022
- Encoded Therapeutics Presents Nonclinical Data Showing Genomic Medicine Platform Yields Selective Expression to Optimize Gene Therapy Performance at... - May 20th, 2022
- California, Other States to Cover Rapid WGS of Newborns Under Medicaid, but Questions of Access Loom - GenomeWeb - May 20th, 2022
- Researchers Identify Role of 'Sonic the Hedgehog' Gene in Bone Repair - BioSpace - May 20th, 2022
- Targeting the Uneven Burden of Kidney Disease on Black Americans - The New York Times - May 20th, 2022
- ASC Therapeutics, U Mass Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine... - May 20th, 2022
- UC Davis Looks to Expand Genetic Breast Cancer Risk Education, Outreach for Hispanic Women - Precision Oncology News - May 20th, 2022
- Fly Researchers Find Another Layer to the Code of Life - Duke Today - May 20th, 2022
- CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Business... - May 20th, 2022
- Omicron BA.4 and BA.5: What to know about the new variants - Medical News Today - May 20th, 2022
- Krystal Biotech to Present Additional Data on B-VEC from the GEM-3 Phase 3 Study at the Society for Investigative Dermatology Annual Meeting -... - May 20th, 2022
- FDA approves Lilly's Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2... - May 20th, 2022
- Elucidating the developmental origin of life-sustaining adrenal glands | Penn Today - Penn Today - May 20th, 2022
- 5 questions facing gene therapy in 2022 - BioPharma Dive - January 17th, 2022
- In a First, Man Receives a Heart From a Genetically Altered Pig - The New York Times - January 17th, 2022
- Antibodies, Easy Single-Cell, Genomics for All: Notes from the JP Morgan Healthcare Conference - Bio-IT World - January 17th, 2022
- Using genetics to conserve wildlife - Pursuit - January 17th, 2022
- Genetics of sudden unexplained death in children - National Institutes of Health - January 17th, 2022
- Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance - Yahoo Finance - January 17th, 2022
- Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically... - January 17th, 2022
- How The mRNA Vaccines Were Made: Halting Progress and Happy Accidents - The New York Times - January 17th, 2022
- Press Registration Is Now Open for the 2022 ACMG Annual Clinical Genetics Meeting - PRNewswire - January 17th, 2022
- A Novel Mutation in the TRPM4 Gene | RRCC - Dove Medical Press - January 17th, 2022
- Biomarkers and Candidate Therapeutic Drugs in Heart Failure | IJGM - Dove Medical Press - January 17th, 2022
- Genetic counseling program helps patients take control of their health - Medical University of South Carolina - June 24th, 2021
- One-year-old baby in UAE receives imported genetic medicine to treat rare disease - Gulf News - June 24th, 2021
- Black and non-Hispanic White Women Found to Have No Differences in Genetic Risk for Breast Cancer - Cancer Network - June 24th, 2021
- What's in your genes | The Crusader Newspaper Group - The Chicago Cusader - June 24th, 2021
- Immusoft Announces Formation of Scientific Advisory Board - Business Wire - June 24th, 2021
- Arrowhead Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress - Business... - June 24th, 2021
- Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole - GlobeNewswire - June 24th, 2021
- Despite the challenges of COVID-19, Yale-PCCSM section members continued their work on scientific papers - Yale School of Medicine - June 24th, 2021
- Veritas Intercontinental: Genetics makes it possible to identify cardiovascular genetic risk and prevent cardiac accidents such as those that have... - June 24th, 2021
- New Research Uncovers How Cancers with Common Gene Mutation Develop Resistance to Targeted Drugs - Newswise - June 24th, 2021
- Celebrate the Third Annual Medical Genetics Awareness Week April 13-16, 2021 - PRNewswire - February 14th, 2021
- How will WNY fare in the race between vaccines and coronavirus variants? - Buffalo News - February 14th, 2021
- Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences - GlobeNewswire - February 14th, 2021
- ASCO GU 2021: The Landscape of Genetic Alterations Using ctDNA-based Comprehensive Genomic Profiling in Pat... - UroToday - February 14th, 2021
- The Human Genome and the Making of a Skeptical Biologist - Scientific American - February 14th, 2021
- Breast Cancer Gene Mutations Found in 30% of All Women - Medscape - February 1st, 2021
- Mysterious untreatable fevers once devastated whole families. This doctor discovered what caused them - CNN - February 1st, 2021
- CCMB team identifies variants of genes that metabolise drugs - BusinessLine - February 1st, 2021
- NeuBase Therapeutics Announces Acquisition of Gene Modulating Technology from Vera Therapeutics - GlobeNewswire - February 1st, 2021
- Copy number variations linked to autism have diverse but overlapping effects - Spectrum - February 1st, 2021
- Genomes, Maps, And How They Affect You - IFLScience - February 1st, 2021
- SMART Study Finds 22q11.2 Microdeletion Prevalence Much Higher than Expected - PRNewswire - February 1st, 2021
- Are Phages Overlooked Mediators of Health and Disease? - The Scientist - February 1st, 2021
- When Your Chance for a Covid Shot Comes, Dont Worry About the Numbers - Kaiser Health News - February 1st, 2021
- Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and... - February 1st, 2021
- The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene MutationExtraordinary Results With Sotorasib - SurvivorNet - February 1st, 2021
- Genetic Testing: MedlinePlus - January 29th, 2021
- 21 Common Genetic Disorders: Types, Symptoms, Causes ... - January 29th, 2021
- Genetic Counseling Online Course - School of Medicine ... - January 29th, 2021